Speakers: 

Gionna Knauss, PharmD, PGY2 Resident, Geisinger - has nothing to disclose.

Chandrakala Dadeboyina, MD, PGY5 Hematology/Oncology Fellow, Geisinger - has nothing to disclose.

Moderator: 

Tristan Maiers, PharmD, BCOP, PGY2 Residency Program Director, Geisinger - has nothing to disclose. 

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

• Describe drug information for cyclosporine and tacrolimus
• Review literature behind both cyclosporine and tacrolimus for GVHD prophylaxis
• Debate choice of use between cyclosporine and tacrolimus for GVHD prophylaxis

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Tristan Maiers, PharmD, BCOP, Rajiv Panikkar, MD, Michele Long, BSN, Jaime Weeder, NP and Christopher Kashi, PA-C have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPPA compliant. 

Commerical Support for this Session

None.